Anti-Alpha Synuclein N-terminal Antibody [11D4]

(No reviews yet) Write a Review
SKU:
STMA00225
Antibody Type:
Monoclonal
Applications:
WB
Applications:
IHC
Reactivity:
Human
Reactivity:
Mouse
Reactivity:
Rat
Host Species:
Mouse
Isotype:
IgG1
  • Western blot analysis comparing STMA00225 with STPA00086 showing differences in detection of Recombinant Human Alpha Synuclein aa 1-114 Monomer, Recombinant Human Alpha Synuclein-98 Monomer, and Recombinant Human Alpha Synuclein Full-length Monomers. Block: 5% skim milk for 1/2 hour at RT.
  • Immunohistochemistry analysis with Mouse Anti-Human Alpha Synuclein N-Terminal Monoclonal Antibody, Clone 11D4 (STMA00225). Tissue: Striatum sections of Parkinson’s Diseased Brain. Species: Human. Fixation: Paraffin embedded, 5um thin. Blocking: 3% milk for 1 hour at RT. Antigen Retrieval: Citrate buffer, pH 6.0, boiled for 20 min. Primary Antibody: Mouse Anti-Human Alpha Synuclein N-Terminal Monoclonal Antibody, Clone 11D4 (STMA00225).
  • Dot blot analysis comparing STMA00225 with STPA00086 and STMA00193 showing differences in detection of Recombinant Human Alpha Synuclein aa 1-114 Monomer, Recombinant Human Alpha Synuclein-98 Monomer, and Recombinant Human Alpha Synuclein Full-length Monomer. Block: 5% skim milk for 1/2 hour at RT.
  • Western blot analysis with STMA00225 showing detection of Alpha Synuclein protein in rat brain and mouse brain lysates. Block: 5% skim milk for 1/2 hour at RT. Primary Antibody: Mouse Anti-Human Alpha Synuclein N-terminal Monoclonal [11D4] (STMA00225) at 1:1000 for 1 hour at RT. Secondary Antibody: Goat anti-mouse IgG-HRP (Rockland Cat# 610-103-121) at 1:4000 for 1/2 hour at RT.
Frequently bought together:

Description

Alpha Synuclein N-terminal Antibody [11D4]

Alpha Synuclein N-terminal Antibody [11D4] is a mouse monoclonal antibody directed against Alpha Synuclein N-terminal, offered by Assay Genie for research applications. Reported applications include WB and IHC. Reported reactivity: Human, Mouse and Rat. Supplied as IgG1, purified by Protein G.

Alpha-synuclein is a presynaptic neuronal protein implicated in the pathogenesis of several neurodegenerative diseases, including Parkinson’s disease and dementia with Lewy bodies. Among its structural domains, the N-terminal region plays a pivotal role in membrane binding, conformational dynamics, and aggregation behavior. Post-translational modifications, particularly C-terminal truncations, significantly influence alpha-synuclein’s aggregation propensity and neurotoxicity (1). C-terminally truncated alpha-synuclein species are highly enriched in pathological inclusions such as Lewy bodies and Lewy neurites. These truncated forms exhibit accelerated fibrillization and enhanced prion-like propagation in cellular and animal models of Parkinson’s disease, underscoring their pathogenic relevance (1). Importantly, such truncations can alter the structural conformation of alpha-synuclein, masking epitopes commonly targeted by antibodies, including those recognizing phosphorylated serine 129 (pSer129). This epitope masking has critical implications for research and diagnostics. Antibodies specific to pSer129 may fail to detect C-terminally truncated alpha-synuclein, potentially underestimating the burden of pathogenic species in tissue samples. Therefore, careful selection of antibodies that target the N-terminal region is essential for accurate detection and quantification of disease-relevant alpha-synuclein conformers (3). Understanding the structural and functional roles of the alpha-synuclein N-terminus is vital for elucidating disease mechanisms and developing targeted therapeutic strategies in synucleinopathies. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

View AllClose

0 Reviews

View AllClose